These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8549314)

  • 1. In vitro activity of new quinolones against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Drugs; 1995; 49 Suppl 2():233-4. PubMed ID: 8549314
    [No Abstract]   [Full Text] [Related]  

  • 2. Quinolone activity against anaerobes.
    Appelbaum PC
    Drugs; 1999; 58 Suppl 2():60-4. PubMed ID: 10553708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinolone activity against anaerobes: microbiological aspects.
    Appelbaum PC
    Drugs; 1995; 49 Suppl 2():76-80. PubMed ID: 8549420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New quinolones: similarities and differences].
    Levi GC
    AMB Rev Assoc Med Bras; 1989; 35(5):202-6. PubMed ID: 2486418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of anaerobic bacteria to temafloxacin.
    Southern PM; Patel S
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S334. PubMed ID: 8391861
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro and in vivo antibacterial activities of broad spectrum quinolones against clinical bacterial isolates.
    Matsumoto T; Tateda K; Ishii Y; Ohno A; Miyazaki S; Yamaguchi K
    Drugs; 1995; 49 Suppl 2():219-21. PubMed ID: 8549309
    [No Abstract]   [Full Text] [Related]  

  • 7. [In vitro antibacterial activity of lomefloxacin, a new fluoroquinolone, against hospital strains. Results of a multicenter study].
    Soussy CJ; Le Van Thoi J; Morel C; Acar JF; Thabaut A; Fleurette J; Vallée E; Dabernat H; Chanal M; Drugeon H
    Pathol Biol (Paris); 1990 May; 38(5):390-6. PubMed ID: 2195448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianaerobic activity of a novel fluoroquinolone, WCK 771, compared to those of nine other agents.
    Peric M; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3188-92. PubMed ID: 15273148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative antianaerobic activity of BMS 284756.
    Hoellman DB; Kelly LM; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2001 Feb; 45(2):589-92. PubMed ID: 11158759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
    Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinolones in perspective.
    Neu HC
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():1-6. PubMed ID: 2258336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of Bulgarian propolis against 94 clinical isolates of anaerobic bacteria.
    Boyanova L; Kolarov R; Gergova G; Mitov I
    Anaerobe; 2006 Aug; 12(4):173-7. PubMed ID: 16919977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.
    Edmiston CE; Krepel CJ; Kehl KS; Seabrook GR; Somberg LB; Almassi GH; Smith TL; Loehrl TA; Brown KR; Lewis BD; Towne JB
    J Antimicrob Chemother; 2005 Nov; 56(5):872-8. PubMed ID: 16186167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of E-4441, a representative azetidine quinolone.
    Esteve M; Moros M; Coll R; Xicota MA; Llovera S
    Drugs Exp Clin Res; 1990; 16(9):445-9. PubMed ID: 2100245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of lomefloxacin (NY-198 or SC-47111), a new difluoro-quinolone.
    Jones RN
    J Chemother; 1989 Jul; 1(4 Suppl):165-7. PubMed ID: 16312353
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activity of ABT-492 against anaerobic bacteria.
    Sillerström E; Wahlund E; Nord CE
    J Chemother; 2004 Jun; 16(3):227-9. PubMed ID: 15330316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of MF 5137, a new potent 6-aminoquinolone.
    Wise R; Pagella PG; Cecchetti V; Fravolini A; Tabarrini O
    Drugs; 1995; 49 Suppl 2():272-3. PubMed ID: 8549329
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
    Mirelis B; Navarro F; Miró E; Coll R; Xicota MA; Prats G
    Drugs Exp Clin Res; 1995; 21(4):129-38. PubMed ID: 8529525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple and sensitive quality control method of the anaerobic atmosphere for identification and antimicrobial susceptibility testing of anaerobic bacteria.
    Justesen T; Justesen US
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):138-40. PubMed ID: 23535206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of microorganisms recovered from intraabdominal infections at Belo Horizonte, Brazil.
    dos Santos SG; de Carvalho MA; Serufo JC; Pinto-Silva RA; Albuquerque W; Rosa RV; Pires Ade F; Hahn RC; Hamdan JS; Nicoli JR; Farias Lde M
    Am J Infect Control; 2004 Nov; 32(7):414-6. PubMed ID: 15525917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.